Posts filtered by tags: Icahn School of Medicine[x]


 

As the pandemic shatters Americans' mental health, the FDA, psychiatrists, and developers are betting on smartphone apps to treat them directly

A woman seen walking past a charity's shopfront in Stoke-on-Trent, England, on October 28, 2020. Nathan Stirk/Getty Images The COVID-19 pandemic has exacerbated the US mental-health crisis, with apps like Calm and Headspace booming as people try to cope. Now, a new cohort of apps are working to directly treat mental illness, rather than just help people get by. Three such companies told Business Insider their programs can drive similar results as medication, and said they believe in-pe...
Tags: Apple, Google, Facebook, Washington Post, US, Trends, Mental Health, Depression, Healthcare, News UK, Cambridge, Food And Drug Administration, Fda, Haim, Apple Store, Digital Health


We're likely to need coronavirus booster shots after the initial vaccine

A volunteer receives an experimental coronavirus shot from a medical worker at Baragwanath Hospital in Soweto, South Africa, June 24, 2020. REUTERS/Siphiwe Sibeko People may need to get booster shots after the initial coronavirus vaccine doses in order to stay protected, experts say. Other vaccines, like the tetanus shot, also require periodic boosters.  That adds further complication to the impending challenge of distributing coronavirus vaccines, which are likely to require two doses. Vi...
Tags: Health, Science, News, New York City, Trends, Pfizer, University of Oxford, Vaccines, Mount Sinai, Chicago Illinois, Soweto South Africa, Icahn School of Medicine, ORENSTEIN, Moderna, Siphiwe Sibeko, Aylin Woodward


Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.

Mustafa Gerek participates in a coronavirus vaccine trial at Ankara City Hospital in Ankara, Turkey, October 13, 2020. Aytac Unal/Anadolu Agency via Getty Images The coronavirus vaccine candidates from Pfizer and Moderna both prevented COVID-19 in clinical trials. Research suggests the coronavirus is genetically stable, which means it mutates very slowly. So the leading vaccines should work well long-term against all strains of the virus. By contrast, viruses like the flu accumulate geneti...
Tags: Health, Science, News, China, Trends, Paris, Switzerland, Fda, Pfizer, Vaccines, Seattle, Mutations, Wuhan, Mount Sinai, Don, Bedford


Moderna's coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated

A nurse prepares a coronavirus vaccine developed by Moderna and the National Institutes of Health, July 2020. Hans Pennink/AP Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. The vaccine requires two shots administered four weeks apart, which could make distribution more complicated. People may need additional booster shots later, experts say. Visit Business Insider's homepage for more stories. Two co...
Tags: Health, Science, News, Massachusetts, Trends, Turkey, Astrazeneca, National Institutes of Health, Pfizer, Anthony Fauci, Mount Sinai, Boston Globe, Johnson Johnson, Icahn School of Medicine, Cambridge Massachusetts, NBC s Today


Diabetes drug can ameliorate lives of chronic heart failure patients

Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Tags: Health, Icahn School of Medicine


Pfizer's coronavirus vaccine requires 2 shots given 3 weeks apart, which could make distribution more complicated

A volunteer receives an experimental vaccine for the coronavirus as part of a Pfizer clinical trial at the University of Maryland. University of Maryland Pfizer's coronavirus vaccine candidate is more than 90% effective in preventing COVID-19, the company announced Monday.  The vaccine involves two shots administered three weeks apart. People may later need additional booster shots too, experts say. Visit Business Insider's homepage for more stories. Pfizer's coronavirus vaccine candidate ...
Tags: Health, Science, News, Trends, Turkey, Food And Drug Administration, HPV, Astrazeneca, Pfizer, Vaccines, Seattle, Mount Sinai, Icahn School of Medicine, ORENSTEIN, Moderna, Thomas Peter Reuters


Heart rate data from wearable devices helps predict SARS-CoV-2 infection

A team of scientists from the Icahn School of Medicine at Mount Sinai in the United States has developed a digital platform to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and related symptoms in healthcare personnel.
Tags: Health, United States, Mount Sinai, Icahn School of Medicine


Scientists say New York City likely had COVID-19 infections in February, weeks earlier than official data suggests

Frank Franklin II/Associated Press SARS-CoV-2, the virus that causes COVID-19, may have been present in New York City in mid-February, according to a study published Tuesday in the Nature journal. The city's first case wasn't officially confirmed until March. Scientists at the Icahn School of Medicine at Mount Sinai Hospital and Mount Sinai Health System found antibodies to the virus in blood plasma samples from mid-February. Around one in five New York City residents had been infected by...
Tags: New York, New York City, Trends, Mount Sinai, Mount Sinai Hospital, Icahn School of Medicine, Mount Sinai Health System, New York City Read, Frank Franklin II Associated Press, Grace Dean, Mount Sinai Health System They


Evidence of robust and persistent antibodies against SARS-CoV-2

A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection?
Tags: Health, Icahn School of Medicine, Mount Sinai New York


Scientists engineer new cancer immunotherapy to train immune system in cancer fight

A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are paired with a therapeutic component, according to a study published in Cell in October.
Tags: Science, Mount Sinai, Icahn School of Medicine


Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.
Tags: Science, Mount Sinai, Icahn School of Medicine


Scientists identify new therapeutic targets for SARS-CoV-2

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.
Tags: Health, Mount Sinai, Icahn School of Medicine, New York Genome Center New York University


Mount Sinai to receive more than $7.3 million as part of NCI's new Serological Sciences Network

Researchers from the Icahn School of Medicine at Mount Sinai will receive more than $7.3 million from the National Cancer Institute as part of the NCI's new Serological Sciences Network (SeroNet), one of the largest coordinated national efforts to study immunology and SARS-CoV-2, the virus that causes COVID-19.
Tags: Health, Mount Sinai, National Cancer Institute, Icahn School of Medicine, NCI, Serological Sciences Network, Serological Sciences Network SeroNet


Trump's doctor says the president already has antibodies. That might not mean he is cured with long-term immunity — it could just be his medication.

Dr. Sean Conley, physician to President Trump, at the Walter Reed National Military Medical Center in Bethesda, Md. AP Photo/Jacquelyn Martin Trump's doctor announced that lab tests showed the president had "detectable levels" of coronavirus antibodies on Wednesday, less than a week after Trump's diagnosis. Your body creates antibodies to help fight off the coronavirus, but research shows these protective proteins take between one and three weeks to develop after you get infected. While ho...
Tags: Health, Science, News, Cdc, White House, San Francisco, Trends, Donald Trump, Detroit, Antibodies, Walter Reed, University Of California, Mount Sinai, Trump, Bloomberg News, Bethesda Md


New antibodies protect mice against lethal infections of influenza B virus

Researchers have identified two antibodies that protect mice against lethal infections of influenza B virus, report scientists at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai.
Tags: Health, St Louis, Washington University School of Medicine, Icahn School of Medicine


Antibodies protect against wide range of influenza B virus strains

Researchers have identified two antibodies that protect mice against lethal infections of influenza B virus, report scientists at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai. Together with an antibody that targets the other major kind of influenza viruses that infect people -- influenza A -- these antibodies potentially could form the basis of a broad-spectrum flu drug that could treat almost all flu cases.
Tags: Science, St Louis, Washington University School of Medicine, Icahn School of Medicine, Mount Sinai Together


Pregnant women with COVID-19 at higher risk for severe illness, health experts say

Pregnant women infected with the novel coronavirus stand a higher risk of becoming severely ill, according to health care professionals who have been monitoring COVID-19’s adverse impacts on expectant mothers and their infants. Thousands of pregnant women across Southern California have tested positive for the novel coronavirus in the past six months. And while two women with preexisting health conditions have died from the virus, medical professionals say most have recovered from their illnesse...
Tags: News, Cdc, New York City, Israel, Los Angeles, Recommended, Sport, Hospitals, Public Health, Soccer, United States, Local News, Orange County, Orange, Southern California, Providence


Limited gut inflammation in COVID-19

A new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in September 2020 shows that gut infection with this virus produces primarily mucosal immunity but also a limited inflammatory response.
Tags: Health, Mount Sinai, Icahn School of Medicine


Underlying pathology of MIS-C in children following SARS-CoV-2 infection

Researchers at the Icahn School of Medicine at Mount Sinai, New York, have conducted a study that sheds light on the molecular underpinnings of multisystem inflammatory syndrome in children (MIS-C).
Tags: Health, Icahn School of Medicine, Mount Sinai New York


Social isolation is hard. New research identifies a potential intervention.

Researchers at Mt. Sinai discovered the neural mechanism behind social isolation. While the studies were conducted on mice, the team hopes this could lead to treatments in humans.This could shed light on social difficulties experienced by autistic and schizophrenic populations. Out of all the unforgettable lyrics by The Beatles, George Harrison's line, "Ah, look at all the lonely people," is one for the ages. How could you possibly live in a city surrounded by millions of people and be lonely?...
Tags: Parenting, Relationships, George Harrison, Brain, Depression, Medical Research, Innovation, Cleveland, Mount Sinai, Derek, Twitter Facebook, Icahn School of Medicine, MetroHealth Medical Center, Morishita, COVID-19, Hirofumi Morishita


2 more people have been reinfected with the coronavirus, European scientists say, a day after the first confirmed reinfection in Hong Kong

A member of medical staff takes coronavirus test samples of a woman during drive-thru coronavirus testing on a converted ice rink, in Alkmaar, Netherlands April 8, 2020. Piroschka van de Wouw/Reuters Reports of people catching the novel coronavirus a second time are starting to trickle in, months into the pandemic.A Belgian woman was reported to have a mild second case, three months after her first illness.And an older person in the Netherlands with a weakened immune system caught the coron...
Tags: South Korea, Hong Kong, New York, Science, News, France, US, Trends, Spain, Public Health, Netherlands, Belgium, World Health Organization, Vaccines, Antibodies, Business Insider


Adolescents with “elevated "hunger" hormone are more likely to develop post-traumatic stress disorder

Chronic stress increases a blood-based hormone called acyl-ghrelin for years after the initial traumatic stressor exposure in some adolescents, and those with elevated levels of the hormone are more likely to develop post-traumatic stress disorder (PTSD) and to experience more severe cases of the condition, according to a study conducted by researchers at the Icahn School of Medicine at Mount Sinai and published August 20 in JAMA Network Open.
Tags: Health, Mount Sinai, Icahn School of Medicine


Lowering acyl-ghrelin levels in traumatized humans could reduce risk and severity of PTSD

Chronic stress increases a blood-based hormone called acyl-ghrelin for years after the initial traumatic stressor exposure in some adolescents, and those with elevated levels of the hormone are more likely to develop post-traumatic stress disorder (PTSD) and to experience more severe cases of the condition, according to a study conducted by researchers at the Icahn School of Medicine at Mount Sinai and published August 20 in JAMA Network Open.
Tags: Health, Mount Sinai, Icahn School of Medicine


COVID-19 causes significant dilation of lung blood vessels, indicates study

A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
Tags: Health, Mount Sinai, Icahn School of Medicine


Dilated blood vessels in the lung may explain low oxygen levels in severe cases of COVID-19

A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
Tags: Science, Mount Sinai, Icahn School of Medicine


Influenza viruses can spread through dust, fibers, and other microscopic particles

Influenza viruses can spread through the air on dust, fibers and other microscopic particles, according to new research from the University of California, Davis and the Icahn School of Medicine at Mt. Sinai.
Tags: Health, University of California Davis, Icahn School of Medicine


Airborne viruses can spread on dust, non-respiratory particles

Influenza viruses can spread through the air on dust, fibers and other microscopic particles, according to new research from UC Davis and the Icahn School of Medicine at Mt. Sinai. The findings, with obvious implications for coronavirus transmission as well as influenza, are published Aug. 18, 2020 in Nature Communications.
Tags: Science, UC Davis, Icahn School of Medicine


SARS-CoV-2 viral load predicts risk of death

As the coronavirus pandemic evolved, there have been many developments in testing for the SARS-CoV-2 viral load in patients. Now, a team of researchers at the Icahn School of Medicine at Mount Sinai, New York, has found that the SARS-CoV-2 viral load can predict mortality in patients with coronavirus disease (COVID-19).
Tags: Health, Icahn School of Medicine, Mount Sinai New York


Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have launched the COVID-19 Unit for Research at Elmhurst (CURE-19).
Tags: Health, Mount Sinai, Icahn School of Medicine, Elmhurst, NYC Health Hospitals, Arnhold Institute for Global Health


Researchers discover treatment for severe auto inflammatory syndrome

Researchers from the Icahn School of Medicine used a novel genetic sequencing technology to identify the genetic cause of--and a treatment for--a previously unknown severe auto inflam-matory syndrome affecting an 18-year-old girl since infancy.
Tags: Health, Icahn School of Medicine